On May 11, 2022 KemPharm, Inc. (NasdaqGS: KMPH) (KemPharm, or the Company), a specialty pharmaceutical company focused on the discovery and development of novel treatments for rare central nervous system (CNS) diseases, reported that members of management will participate in three upcoming in-person investor conferences (Press release, KemPharm, MAY 11, 2022, View Source [SID1234614234]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details regarding KemPharm’s presentations are as follows:

Event: RBC Capital Markets Global Healthcare Conference (Fireside Chat)
Date: May 18, 2022
Time: 2:35 p.m., EDT
Location: InterContinental Barclay, New York, NY

Event: H.C. Wainwright Global Investment Conference
Date: May 25, 2022
Time: 3:30 p.m., EDT
Location: Fontainebleau Miami Beach Hotel, Miami Beach, FL

Event: JMP Securities 2022 Life Sciences Conference
Date: June 15, 2022
Time: 12:30 p.m., EDT
Location: Lotte New York Palace, New York, NY
Management will be available for one-on-one meetings with registered attendees at each respective conference. Live webcasts of these events will be available under the "Events & Presentations" within the Investor Relations section of the Company’s website at View Source